These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10933697)

  • 1. Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.
    Flanagan EB; Ball LA; Wertz GW
    J Virol; 2000 Sep; 74(17):7895-902. PubMed ID: 10933697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice.
    Flanagan EB; Schoeb TR; Wertz GW
    J Virol; 2003 May; 77(10):5740-8. PubMed ID: 12719567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.
    Clarke DK; Nasar F; Lee M; Johnson JE; Wright K; Calderon P; Guo M; Natuk R; Cooper D; Hendry RM; Udem SA
    J Virol; 2007 Feb; 81(4):2056-64. PubMed ID: 17151112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus.
    Ball LA; Pringle CR; Flanagan B; Perepelitsa VP; Wertz GW
    J Virol; 1999 Jun; 73(6):4705-12. PubMed ID: 10233930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric measles viruses with a foreign envelope.
    Spielhofer P; Bächi T; Fehr T; Christiansen G; Cattaneo R; Kaelin K; Billeter MA; Naim HY
    J Virol; 1998 Mar; 72(3):2150-9. PubMed ID: 9499071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.
    Flanagan EB; Zamparo JM; Ball LA; Rodriguez LL; Wertz GW
    J Virol; 2001 Jul; 75(13):6107-14. PubMed ID: 11390612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant vesicular stomatitis virus bearing a lethal mutation in the glycoprotein gene uncovers a second site suppressor that restores fusion.
    Stanifer ML; Cureton DK; Whelan SP
    J Virol; 2011 Aug; 85(16):8105-15. PubMed ID: 21680501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA cap methylation influences pathogenesis of vesicular stomatitis virus in vivo.
    Ma Y; Wei Y; Zhang X; Zhang Y; Cai H; Zhu Y; Shilo K; Oglesbee M; Krakowka S; Whelan SP; Li J
    J Virol; 2014 Mar; 88(5):2913-26. PubMed ID: 24371058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression.
    Wertz GW; Moudy R; Ball LA
    J Virol; 2002 Aug; 76(15):7642-50. PubMed ID: 12097578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    Li J; Chorba JS; Whelan SP
    J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice.
    Steinhoff U; Müller U; Schertler A; Hengartner H; Aguet M; Zinkernagel RM
    J Virol; 1995 Apr; 69(4):2153-8. PubMed ID: 7884863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages.
    Novella IS; Ball LA; Wertz GW
    J Virol; 2004 Sep; 78(18):9837-41. PubMed ID: 15331718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host.
    Martinez I; Rodriguez LL; Jimenez C; Pauszek SJ; Wertz GW
    J Virol; 2003 Jul; 77(14):8039-47. PubMed ID: 12829843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.
    Ferran MC; Lucas-Lenard JM
    J Virol; 1997 Jan; 71(1):371-7. PubMed ID: 8985359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins.
    Lay Mendoza MF; Acciani MD; Levit CN; Santa Maria C; Brindley MA
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33348746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.
    Janelle V; Brassard F; Lapierre P; Lamarre A; Poliquin L
    J Virol; 2011 Jul; 85(13):6513-20. PubMed ID: 21561919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular Stomatitis Virus Phosphoprotein Dimerization Domain Is Dispensable for Virus Growth.
    Gérard FCA; Jamin M; Blackledge M; Blondel D; Bourhis JM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
    Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus.
    Perez M; Clemente R; Robison CS; Jeetendra E; Jayakar HR; Whitt MA; de la Torre JC
    J Virol; 2007 Jun; 81(11):5527-36. PubMed ID: 17376911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-based design of growth-attenuated viruses.
    Lim KI; Lang T; Lam V; Yin J
    PLoS Comput Biol; 2006 Sep; 2(9):e116. PubMed ID: 16948530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.